MedPath

Mobile App in Addiction

Not Applicable
Completed
Conditions
Addiction
Interventions
Device: ASC
Registration Number
NCT04133688
Lead Sponsor
Assistance Publique - Hôpitaux de Paris
Brief Summary

The sleep and behavior agendas are today very largely underused while they can be of a considerable contribution in the follow-up of the patients and the reinforcement of the therapeutic alliance. In the management of addictions, sleep disorders are a major comorbidity, these two components maintain indeed complex links: it was highlighted a bidirectional relationship between the effect of the consumption of addictive substances on sleep and conversely, the effect of sleep disorders on the consumption of products, the same is true for overexposure to screens.

Detailed Description

The sleep and behavior agendas are today very largely underused while they can be of a considerable contribution in the follow-up of the patients and the reinforcement of the therapeutic alliance. In the management of addictions, sleep disorders are a major comorbidity, these two components maintain indeed complex links: it was highlighted a bidirectional relationship between the effect of the consumption of addictive substances on sleep and conversely, the effect of sleep disorders on the consumption of products, the same is true for overexposure to screens.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
36
Inclusion Criteria
  • Teenagers or young adults from 12 to 18 years old (included)
  • Consultant for addiction to cannabis and / or tobacco and / or alcohol and / or screen
  • Treated within the Functional Unit of addictology
  • For minors, after parental consent
Exclusion Criteria

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Mobile application (ASC)ASCmobile app / devise
Paper diaryASCpaper diary
Primary Outcome Measures
NameTimeMethod
Number of days filled for sleep and consumptions, usable by the doctor on the day of the consultation / after 15 days of self-evaluation required by the treatment15 days
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Robert Debre Hospital

🇫🇷

Paris, France

© Copyright 2025. All Rights Reserved by MedPath